Cordova, Tenn.-based Aesthetic Management Partners, a medical device and biologics company in the functional medicine and aesthetic industry, has obtained a significant growth funding package from Decathlon Capital Partners. Details of the transaction were not disclosed.
Aesthetic Management Partners will use the funding to support its long-term expansion initiatives, according to company officials. Aesthetic Management Partners provides nationwide brand development and distribution as it partners with global manufacturers of medical devices and biologics to accelerate their introduction into the U.S. market.
Erik Dowell, CEO and co-founder of Aesthetic Management Partners, says the company’s growth is driven by its suite of medical devices and biologic products. “Our promise is to deliver optimal patient outcomes to our medical practitioners,” he says. “If it is good for the patient, good for the physician and good for our company, then it is the right course of action. This guides us in everything we do.”
Adrian Bishop, president and Co-Founder of Aesthetic Management Partners, says the transaction with Decathlon Capital Partners provides the flexibility his company needs to support its growth initiatives. “Decathlon’s unique growth capital model enables us to continue to invest in key markets without diluting our shareholders. Its funding model perfectly aligns with our expansion strategy as a privately held company. We look forward to working with Decathlon.”
Kevin Grossman, vice president of Decathlon Capital Partners, also spoke out about the partnership, commenting: “The lean, disciplined approach of Aesthetic Management Partners and its team of professional sales executives provide a solid foundation to support expansion into new market sectors.”
